Brief: Revvity Receives FDA Clearance For Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution
13/05/2026 13:04
May 13 (Reuters) - Revvity Inc RVTY.N: REVVITY RECEIVES FDA CLEARANCE FOR TOTAL TESTOSTERONE ASSAY ENABLING COMPREHENSIVE AUTOMATED TESTOSTERONE TESTING SOLUTION Source text: ID:nBw3KTR2ra Further company coverage: RVTY.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revvity
See all newsBrief: Revvity Launches Signals Labgistics Solution To Connect And Orchestrate Scientific Workflows
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT